Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Insulin Aspart MeSH Descriptor Data 2025


MeSH Heading
Insulin Aspart
Tree Number(s)
D06.472.699.587.200.400.100
D12.644.548.586.200.400.100
Unique ID
D061267
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D061267
Scope Note
Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.
Entry Term(s)
B28-Asp-Insulin
Insulin B28asp
Insulin, Aspartic Acid(B28)-
Insulin-Aspart
NovoLog
NovoRapid
Pharm Action
Hypoglycemic Agents
Registry Numbers
D933668QVX
0
Public MeSH Note
2012; INSULIN ASPART was indexed under INSULIN 1991-2011
History Note
2012(1991)
Entry Combination
antagonists & inhibitors:Insulin Antagonists
Date Established
2012/01/01
Date of Entry
2011/06/24
Revision Date
2016/07/01
Insulin Aspart Preferred
NovoLog Narrower
page delivered in 0.13s